Search Results 1551-1560 of 19428 for hemoglobin

1. Association between individualized metabolic surgery scores and weight-loss outcomes in patients treated with semaglutide - Mayo Clinic

   It includes four parameters: glycemic control (hemoglobin A1C less than 7%), insulin use, number of T2DM medications and duration of T2DM. Because the ...

2. Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (obtained ≤ 14 days prior to randomization). Untransfused platelet count ≥ 75,000 cells/mm^3 (obtained ≤ 14 days prior to ...

3. A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus - Mayo Clinic

   Clinically significant abnormal hematology (white blood cell count less than 3 or greater than 10 x 10^9/L, hemoglobin less than 9.5 or greater than 15.5 g ...

4. Neurosurgery - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

5. A Study of Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) - Mayo Clinic

   Hemoglobin ≥ 9 g/dL;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN) (isolated bilirubin > 1.5 x ULN is acceptable if bilirubin is fractionated and ...

6. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Hemoglobin < 10g /100 mL for male and < 9g/ 100 mL for female;; Platelets < 100 000/mm^3;; Creatinine ≥ 150 μmol/L. Patients on macrolide (e.g., azithromycin) ...

7. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

   Hemoglobin A1C > 7%, confirmed by repeat testing;; Positive blood screen for human immunodeficiency virus (HIV), hepatitis C antibody, or hepatitis B surface ...

8. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

   The subject has, in the judgment of the investigator, clinically significant abnormal hematological parameters of hemoglobin, hematocrit, or erythrocytes at ...

9. A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) Device In Patients With Recurrent GBM - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL. 13. Have a negative pregnancy test within 14 days prior to registration on study (for FOCBP, female of child-bearing potential) 14 ...

10. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (at least 7 days since most recent blood transfusion). Adequate renal laboratory assessments, as follows: Estimated creatinine ...